PRF Technologies (PRFX) Other Working Capital Changes (2023 - 2024)

PRF Technologies (PRFX) recorded quarterly Other Working Capital Changes of $1000.0 in Q2 2024, up 133.33% on a QoQ basis from -$3000.0 in Q1 2024.

PRF Technologies (PRFX) Other Working Capital Changes (2023 - 2024) Analysis & Trends

PRF Technologies has disclosed Other Working Capital Changes across 2 years of filings, most recently posting $1000.0 for Q2 2024.

Quarterly Other Working Capital Changes changed N/A year-over-year to $1000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$11000.0 (changed N/A YoY) and the FY2025 annual result came in at $22000.0, up 320.0% from the prior year.
Other Working Capital Changes climbed to $1000.0 in Q2 2024, from -$3000.0 in the prior quarter.
Over five years, Other Working Capital Changes peaked at $1000.0 in Q2 2024 and troughed at -$9000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	PRF Technologies	933,081.16	-2.46 Mn	-

Download Data